Medical Device Development - Trends, Challenges and Risks
•
2 likes•1,074 views
This document discusses trends, challenges, and risks in medical device development. Some key trends include a shift towards personalized medicine, replacing organs and tissues, increased mobile access to healthcare information, and a focus on prevention over treatment. Technological advances are enabling smaller, more powerful devices for imaging, surgery, and managing medical information. However, medical device development faces challenges such as high costs, lengthy regulatory processes, reimbursement uncertainties, and ensuring cybersecurity. The document also outlines strengths and weaknesses in software for medical devices as well as risks at different stages of the medical device lifecycle.
Report
Share
Report
Share
Download to read offline
Recommended
Medical device development lifecycle
A walk through the device development continuum. Great for inventors, investors, product managers, regulators and more.
Medical devices introduction
This document provides an introduction to medical devices. It begins with definitions of medical devices as any instrument intended for medical use to diagnose, treat or alleviate disease or injury. Major groups of instruments are identified as surgical, dental/orthopedic, ophthalmology, implants and diagnostic devices. Classification of devices is described based on risk levels related to device type, duration of use, contact and anatomy. Variants and required materials information are outlined. Process validations are introduced as critical to ensuring consistent product quality and performance from batch to batch.
Efficient Data Reviews and Quality in Clinical Trials - Kelci Miclaus
Kelci Miclaus from SAS JMP: 'Efficient Data Reviews and Quality in Clinical Trials' - presented at Clinical Data Live 2013.
Design for reimbursement in medical device development
In medical device development it is essential to start with reimbursement strategy from day one to enhance the chance to successful implementation in the healthcare system. This presentation shows the outcomes of a 5 month graduation project to the role of reimbursement in medical device development. The design for reimbursement framework proposed provides an overview for starting entrepreneurs in the complex field of medical devices.
Medical devices
To comprehend the regulatory requirements to import medical Medical devices and authorization procedures in regulated markets of the United States and Australia
Providers in U.S Healthcare
This will walk you all through the provider section in U.S Healthcare system.This contains basic information about what is Provider umbrella.
‘Orphan drugs’ future growth potential for indian pharmaceutical market
This document discusses orphan drugs and their potential in the Indian pharmaceutical market. It defines orphan drugs as those developed for rare diseases affecting less than 8% of the population. The US was the first to pass orphan drug legislation in 1983 to incentivize development of these drugs. Similar laws now exist in other countries and provide benefits like 7 years of market exclusivity. While initially developed for small populations, some orphan drugs like Rituxan have become very profitable blockbusters. The global orphan drug market was worth $50 billion in 2011 and is growing faster than other drug markets. Several Indian companies are now developing or manufacturing orphan drugs for rare diseases.
Digital Healthcare - Detailed Presentation PDF
Digital healthcare technologies are transforming healthcare delivery globally. Companies are developing technologies like mobile apps, big data analytics, and smart medical devices to improve patient monitoring and outcomes. These digital innovations extract insights from medical data to enhance healthcare provisioning, reduce costs, and support preventative care and remote patient monitoring. Emerging areas like bioinformatics and medical analytics utilize big data to provide actionable clinical insights.
Recommended
Medical device development lifecycle
A walk through the device development continuum. Great for inventors, investors, product managers, regulators and more.
Medical devices introduction
This document provides an introduction to medical devices. It begins with definitions of medical devices as any instrument intended for medical use to diagnose, treat or alleviate disease or injury. Major groups of instruments are identified as surgical, dental/orthopedic, ophthalmology, implants and diagnostic devices. Classification of devices is described based on risk levels related to device type, duration of use, contact and anatomy. Variants and required materials information are outlined. Process validations are introduced as critical to ensuring consistent product quality and performance from batch to batch.
Efficient Data Reviews and Quality in Clinical Trials - Kelci Miclaus
Kelci Miclaus from SAS JMP: 'Efficient Data Reviews and Quality in Clinical Trials' - presented at Clinical Data Live 2013.
Design for reimbursement in medical device development
In medical device development it is essential to start with reimbursement strategy from day one to enhance the chance to successful implementation in the healthcare system. This presentation shows the outcomes of a 5 month graduation project to the role of reimbursement in medical device development. The design for reimbursement framework proposed provides an overview for starting entrepreneurs in the complex field of medical devices.
Medical devices
To comprehend the regulatory requirements to import medical Medical devices and authorization procedures in regulated markets of the United States and Australia
Providers in U.S Healthcare
This will walk you all through the provider section in U.S Healthcare system.This contains basic information about what is Provider umbrella.
‘Orphan drugs’ future growth potential for indian pharmaceutical market
This document discusses orphan drugs and their potential in the Indian pharmaceutical market. It defines orphan drugs as those developed for rare diseases affecting less than 8% of the population. The US was the first to pass orphan drug legislation in 1983 to incentivize development of these drugs. Similar laws now exist in other countries and provide benefits like 7 years of market exclusivity. While initially developed for small populations, some orphan drugs like Rituxan have become very profitable blockbusters. The global orphan drug market was worth $50 billion in 2011 and is growing faster than other drug markets. Several Indian companies are now developing or manufacturing orphan drugs for rare diseases.
Digital Healthcare - Detailed Presentation PDF
Digital healthcare technologies are transforming healthcare delivery globally. Companies are developing technologies like mobile apps, big data analytics, and smart medical devices to improve patient monitoring and outcomes. These digital innovations extract insights from medical data to enhance healthcare provisioning, reduce costs, and support preventative care and remote patient monitoring. Emerging areas like bioinformatics and medical analytics utilize big data to provide actionable clinical insights.
Pathway 2.0 for RWE and MA 2015 -John Cai
1. The document discusses using real-world big data (RWBD) from sources like insurance claims, EMRs, registries, and devices to analyze real-world treatment pathways and generate real-world evidence (RWE).
2. A case study analyzes longitudinal treatment pathways of patients with non-malignant multiple myeloma using Hadoop and MapReduce to query and merge data from large tables.
3. Visualizations of individual patient timelines and aggregate pathways show variability in treatments and outcomes that could help identify opportunities to improve care management and adherence to guidelines.
plasma master file in European countries and requirements in letter of intent...
This document summarizes the key points of a plasma master file (PMF). A PMF contains all required scientific data on the quality and safety of human plasma used to manufacture medicines, medical devices, and investigational products. It was introduced by the European Union in 2003 to simplify regulatory submissions and ensure consistent evaluation of plasma quality across countries. The certification process involves submitting an application to the European Medicines Agency, which appoints coordinators to evaluate the PMF and issue a certificate valid throughout the EU if compliance is demonstrated. Changes to plasma or products listed in the PMF require recertification through this centralized procedure.
Medical Device: A life changing innovation
This document provides an overview of medical devices:
It defines medical devices as instruments used for medical purposes like diagnosis and treatment. The history section outlines important medical device innovations from the late 19th century to present. Regulations for medical devices are described, including organizations that regulate quality, safety and efficacy. Medical devices are classified based on their risks. The document discusses the drug development process, therapeutic and diagnostic uses of devices, risks, and concludes that benefits generally outweigh risks when proper risk management is followed.
FDA regulation for medical devices
This document provides an overview of FDA regulation of medical devices in the United States. It defines key terms, describes the classification system for devices and corresponding levels of regulatory control. It outlines major premarket and postmarket requirements including establishment registration, 510(k) premarket notification, premarket approval, labeling, quality system regulation, medical device reporting and complaint handling. Major sections cover classification, premarket submissions, labeling and other compliance requirements enforced by the FDA to ensure device safety and effectiveness.
Preparing an IND Application: CMC
Speaker: Peter Pekos, Dalton Pharma Services. Part of the MaRS Best Practices Series.This session, led by seasoned industry experts, will explore how to effectively set up your pre-clinical POC studies, address pre-clinical safety requirements and issues, and give you an overview of the manufacturing standards required for Phase I studies
More information: http://www.marsdd.com/Events/Event-Calendar/Best-Practices-Series/ind-05132008.html
Medical device reporting 27 sep2016
The document discusses medical device adverse event reporting requirements, including definitions of reportable events and timelines for submitting reports to regulatory agencies. It provides an overview of the classification system for medical devices and regulations around reporting malfunctions, deaths and serious injuries caused by devices. Reporting requirements and challenges involving software as a medical device are also reviewed.
Best Practices on Medical Coding in MedDRA
This document discusses best practices for medical coding with MedDRA. It covers issues and decisions around coding practice, such as who should code reports, which terms to code, ensuring coding quality, and optimizing technology. It also discusses issues and decisions around data analysis, such as using standardized MedDRA queries and medical dictionary hierarchies for data retrieval and grouping terms to answer research questions. The presentation aims to provide guidance on medical coding processes and analyses.
Medical device
The document discusses medical device regulation in India. It provides definitions of medical devices and outlines the regulatory bodies that govern them, including the Central Drugs Standard Control Organization (CDSCO). It describes the proposed Indian Medical Devices Regulatory Act (IMRDA) and its objectives to establish standards, classify devices by risk, and regulate safety. The regulation of medical devices in India is still developing, with proposals to expand regulation beyond the limited devices currently covered under the Drugs and Cosmetics Act.
Handling Third Party Vendor Data_Katalyst HLS
The document discusses handling third party vendor data in clinical trials. It covers four types of external data including safety laboratory data, PK/PD data, pharmacogenetics data, and device data. Centralized vendors provide standardized testing across sites and electronic transfer of data to minimize errors. Data reconciliation involves generating discrepancy reports using primary keys like sponsor ID, study ID, and subject ID, and secondary keys like date of birth. Queries are raised to sites or vendors to resolve inconsistencies between third party and clinical trial databases.
Clinical Evaluation of Medical Devices
MEDDEV 2.7/1 revision 4 (June 2016)
Section 6a of Annex I to DIR 93/42/EEC
Section 5a of Annex I to DIR 90/385/EEC
(both amended by DIR 2007/47/EC)
The In vitro diagnostic medical devices regulation (EU) 2017/746: what will c...
The In vitro diagnostic medical devices regulation (EU) 2017/746: what will c...European Center for Disease Prevention and Control (ECDC)
Presentation of the 18th ECDC National Focal Points for Microbiology (NMFP) meeting held on 3-4 May 2018 in StockholmNew drug and ct rules 2019
The document provides information on India's drug regulatory system. It states that the Drug Controller General of India heads the Central Drug Standard Control Organisation, which regulates drugs in India. The objectives of the drug regulatory authority are to ensure medicinal products are of acceptable quality, safe, and effective. It also discusses new drug approval processes, definitions of new drugs, application forms and fees for various regulatory processes like clinical trials, manufacturing, and import of drugs.
Med ra terminology
MedDRA - the Medical Dictionary for Regulatory Activities - is a medical terminology used to classify adverse event information associated with the use of biopharmaceuticals and other medical products (e.g., medical devices and vaccines). Coding these data to a standard set of MedDRA terms allows health authorities and the biopharmaceutical industry to more readily exchange and analyze data related to the safe use of medical products.
Data and Safety Monitoring Board - An Overview
Presentation regarding history, purpose, role, functions, meeting, member responsibilities, report of a Data and Safety Monitoring Board (DSMB)
Medical Product Development cycle
The document provides an overview of the product development cycle for medical devices. It discusses that medical devices are highly regulated and must meet regulatory standards to be approved for use. The development process involves risk analysis, usability testing, clinical evaluation and verification to ensure safety and effectiveness for the intended use before a device can be certified and placed on the market. Standards provide guidelines for quality management, risk management, and specific product categories that must be followed.
FDA Regulation of Promotion & Advertising -- Part 1: The Basics
Presentation to the Compliance Online 2-day course on Ensuring Compliance with FDA Requirements for the Promotion & Advertising of Drugs and Medical Devices, March 22, 2018
summary of indian medical device rule 2017
This document outlines the key points of the Indian Medical Device Rules of 2017. It defines medical devices and explains why regulation is necessary. It describes the various authorities and bodies involved in enforcement and oversight. The rules cover the classification, manufacturing, import, labeling, clinical investigation, and sale of medical devices in India. Manufacturers must comply with quality management standards and obtain the necessary licenses from the Central or State Licensing Authorities depending on the class of device. Clinical investigations require approval and oversight from ethics committees. The rules aim to improve safety, quality and ensure medical devices meet appropriate standards.
PHARMACOVIGILANCE COMMON JOB INTERVIEW QUESTIONS WITH ANSWERS-Updated IN 202...
PHARMACOVIGILANCE COMMON JOB INTERVIEW QUESTIONS WITH ANSWERS-Updated IN 202...Pristyn Research Solutions
Quick Job interview short guide For Pharma and all Life science jobseekers.All Medical | Biotech |Micro |B.Sc., M.Sc.
These are the commonly asked questions with their answers asked in job interviews. The file was updated in 2022.
https://pristynresearch.com/
MAIL ID - pristynresearch@gmail.com
FACEBOOK- https://www.facebook.com/pristynsolutions
INSTAGRAM- https://www.instagram.com/pristyn_res...
TWITTER- https://twitter.com/Pristynresearch
SLIDESHARE- https://www.slideshare.net/azherkhan5916
LINKEDIN- https://www.linkedin.com/in/pristyn-research-191072119/
ADDRESS-
1) Parmar Trade Centre, A-wing,105/106, Sadhu Vaswani Chowk, Pune, 411001. Email: info@pristynresearch.com Phone: 09028839789
2)T-21/4, Opposite To Expert Global, Garware Stadium Road, Software Technology Park of India(STPI), MIDC, Aurangabad-431001. Email: info@pristynresearch.com Call us: 9028839789
Sample Questions are:
What is Pharmacovigilance (PV)?
What are the objectives of PV?
What is MedDRA?
WHAT ARE THE Role of Drug Safety
Associate?
What should narratives consist of?
What are Data assessments in PV?
Which products are covered by PV?
Methods of signal detection?
Why PV is required after clinical
trial?
What is an Adverse Drug Event (ADE)?
What
is the minimum criterion required
for a valid case according to WHO?
When
do you consider an event to be
serious?
What do you mean by causality?
Types of
Unsolicited reports
Sources of Solicited Reports
Name the core regulatory bodies
What is Volume 9A
What do you know
about E2a, E2b and E2c guidelines?
When do you consider a case to be medically confirmed?
What is CemFlow?
What is the yellow card in PV?
What are Comorbid conditions?
What is a medication error?
What is a signal?
Rechallenge
Dechallenge
What are WHO ART, WHO DD and MedDRA and the difference between them?
What is SUSAR?
Adverse Drug Reaction (ADR)
Effectiveness/risk
harm
Essential medicines
Frequency of ADRs
Individual Case Safety Report
ADR Reporting process in PV
VigiFlow
VigiMed
ABBOTTS
COGNIZANT
I 3 GLOBAL DRUG
SAFETY
LAURUS LABS
PARAXEL
SRISTEK
ACCENTURE
CREST.
I GATE PATNI
COMPUTERS
MAHINDRA
SATYAMBSG
PIRAMAL
SUN
PHARMA
ALEMBIC
DIAGNOSEAR
CH
ICON
MAKROCARE
PPD
SYMOGEN
APC PHARMA.
DR REDDY’S
iMEDGlobal,
MANKIND
QUANTUM
SOLUTIONS
SYNOGEN
APCER
ECRON
ACUNOVA
IMS HEALTH
MEDHIMALAYAS
QUINTILES
TAKE
SOLUTIONS
APCER
EMCURE
INC RESEARCH
MEDPACE.
SCIFORMIX
RATIOPHARM
TCS
ASTRAZENECA
FDC
Infocorp
Soft
Solutions
MICRO LABS
RX MD
THOMSON
REUTERS
AUROBINDO
FORTIS
HEALTH CARE
INVENTIVE
MSD (MERCK)
SANTHA
BIOTECH
USV
LIMITED
BESTOCHEM
G7 INFOTECH
IPCA
LABORATORIES
NEKTAR
THERAPEUTICS
SCIFORMIX.
VIMTA LABS
BIOCAD
GENPACT
IPLEX
NORWICH
CLINICAL SERVICES
SHANTHA
BIOTECHNICS
WIPRO
BIOCON
GRANULES
JUBILIANT
BIOSYS NOVARTIS
SIRO
CLINPHARM
WNS
BIOLOGICAL E.
LTD
GVK
KINAPSE
NOVO NORDISK
SP softtech
WOCKHARD
T
BLUEFISH
HCL
LAMBDA
OMNICARECLINICA
L RESEARCH
SRI KRISHNA
PHARMA
4C
Pharma
SolutionsClinical Data Review Best Practices - E. Herbel
The document summarizes best practices for clinical data review. Historically, clinical research associates reviewed 100% of paper case report forms and data was reviewed in exhaustive detail. However, this approach is now seen as inefficient. The current trend is for risk-based data review, where highest risk issues are prioritized. This allows reviewers to focus on important safety data and unexpected trends rather than getting bogged down in minor details. Effective data review examines data from aggregate summaries to identify trends, then allows drilling down to patient-level details to investigate further. Graphical aggregates like scatter plots and risk assessments are also useful review tools to detect outliers.
Safety monitoring and reporting of adverse events of medical devices national...
This document outlines safety monitoring and adverse event reporting for medical devices from national and international perspectives. It defines medical devices and their classification system. Approval processes in India are discussed, along with the Materiovigilance Program of India for post-marketing surveillance. Adverse events must be reported within defined timeframes. International regulatory bodies like the FDA and MHRA also have mandatory reporting requirements. The limitations of current monitoring and reporting are noted.
De vygview a #EdificioOptimista
El documento describe el proyecto de Vygon España para crear una nueva sede de oficinas llamada "Edificio Optimista" que refleje la filosofía y valores de la compañía. El artista Fernando Jiménez diseñó varias obras de arte para decorar las oficinas, incluyendo árboles, fotos y un mapamundi pintado por niños, con el objetivo de fomentar una cultura de optimismo, buen rollo y comunicación entre los empleados.
MEDICAL DEVICE DEVELOPMENT_0327
This document discusses challenges for inventors and investors in raising capital for medical device development. It outlines four levels of innovation risk from lowest to highest - marginal, technological, therapeutic, and radical. Radical innovation involving new technology and new clinical uses poses the highest uncertainty. The document also compares perspectives of inventors, who focus on developing products, and investors, who seek returns. Their differing goals can cause challenges in collaborating on ventures. Additional hurdles include regulatory requirements and changing markets and technologies.
More Related Content
What's hot
Pathway 2.0 for RWE and MA 2015 -John Cai
1. The document discusses using real-world big data (RWBD) from sources like insurance claims, EMRs, registries, and devices to analyze real-world treatment pathways and generate real-world evidence (RWE).
2. A case study analyzes longitudinal treatment pathways of patients with non-malignant multiple myeloma using Hadoop and MapReduce to query and merge data from large tables.
3. Visualizations of individual patient timelines and aggregate pathways show variability in treatments and outcomes that could help identify opportunities to improve care management and adherence to guidelines.
plasma master file in European countries and requirements in letter of intent...
This document summarizes the key points of a plasma master file (PMF). A PMF contains all required scientific data on the quality and safety of human plasma used to manufacture medicines, medical devices, and investigational products. It was introduced by the European Union in 2003 to simplify regulatory submissions and ensure consistent evaluation of plasma quality across countries. The certification process involves submitting an application to the European Medicines Agency, which appoints coordinators to evaluate the PMF and issue a certificate valid throughout the EU if compliance is demonstrated. Changes to plasma or products listed in the PMF require recertification through this centralized procedure.
Medical Device: A life changing innovation
This document provides an overview of medical devices:
It defines medical devices as instruments used for medical purposes like diagnosis and treatment. The history section outlines important medical device innovations from the late 19th century to present. Regulations for medical devices are described, including organizations that regulate quality, safety and efficacy. Medical devices are classified based on their risks. The document discusses the drug development process, therapeutic and diagnostic uses of devices, risks, and concludes that benefits generally outweigh risks when proper risk management is followed.
FDA regulation for medical devices
This document provides an overview of FDA regulation of medical devices in the United States. It defines key terms, describes the classification system for devices and corresponding levels of regulatory control. It outlines major premarket and postmarket requirements including establishment registration, 510(k) premarket notification, premarket approval, labeling, quality system regulation, medical device reporting and complaint handling. Major sections cover classification, premarket submissions, labeling and other compliance requirements enforced by the FDA to ensure device safety and effectiveness.
Preparing an IND Application: CMC
Speaker: Peter Pekos, Dalton Pharma Services. Part of the MaRS Best Practices Series.This session, led by seasoned industry experts, will explore how to effectively set up your pre-clinical POC studies, address pre-clinical safety requirements and issues, and give you an overview of the manufacturing standards required for Phase I studies
More information: http://www.marsdd.com/Events/Event-Calendar/Best-Practices-Series/ind-05132008.html
Medical device reporting 27 sep2016
The document discusses medical device adverse event reporting requirements, including definitions of reportable events and timelines for submitting reports to regulatory agencies. It provides an overview of the classification system for medical devices and regulations around reporting malfunctions, deaths and serious injuries caused by devices. Reporting requirements and challenges involving software as a medical device are also reviewed.
Best Practices on Medical Coding in MedDRA
This document discusses best practices for medical coding with MedDRA. It covers issues and decisions around coding practice, such as who should code reports, which terms to code, ensuring coding quality, and optimizing technology. It also discusses issues and decisions around data analysis, such as using standardized MedDRA queries and medical dictionary hierarchies for data retrieval and grouping terms to answer research questions. The presentation aims to provide guidance on medical coding processes and analyses.
Medical device
The document discusses medical device regulation in India. It provides definitions of medical devices and outlines the regulatory bodies that govern them, including the Central Drugs Standard Control Organization (CDSCO). It describes the proposed Indian Medical Devices Regulatory Act (IMRDA) and its objectives to establish standards, classify devices by risk, and regulate safety. The regulation of medical devices in India is still developing, with proposals to expand regulation beyond the limited devices currently covered under the Drugs and Cosmetics Act.
Handling Third Party Vendor Data_Katalyst HLS
The document discusses handling third party vendor data in clinical trials. It covers four types of external data including safety laboratory data, PK/PD data, pharmacogenetics data, and device data. Centralized vendors provide standardized testing across sites and electronic transfer of data to minimize errors. Data reconciliation involves generating discrepancy reports using primary keys like sponsor ID, study ID, and subject ID, and secondary keys like date of birth. Queries are raised to sites or vendors to resolve inconsistencies between third party and clinical trial databases.
Clinical Evaluation of Medical Devices
MEDDEV 2.7/1 revision 4 (June 2016)
Section 6a of Annex I to DIR 93/42/EEC
Section 5a of Annex I to DIR 90/385/EEC
(both amended by DIR 2007/47/EC)
The In vitro diagnostic medical devices regulation (EU) 2017/746: what will c...
The In vitro diagnostic medical devices regulation (EU) 2017/746: what will c...European Center for Disease Prevention and Control (ECDC)
Presentation of the 18th ECDC National Focal Points for Microbiology (NMFP) meeting held on 3-4 May 2018 in StockholmNew drug and ct rules 2019
The document provides information on India's drug regulatory system. It states that the Drug Controller General of India heads the Central Drug Standard Control Organisation, which regulates drugs in India. The objectives of the drug regulatory authority are to ensure medicinal products are of acceptable quality, safe, and effective. It also discusses new drug approval processes, definitions of new drugs, application forms and fees for various regulatory processes like clinical trials, manufacturing, and import of drugs.
Med ra terminology
MedDRA - the Medical Dictionary for Regulatory Activities - is a medical terminology used to classify adverse event information associated with the use of biopharmaceuticals and other medical products (e.g., medical devices and vaccines). Coding these data to a standard set of MedDRA terms allows health authorities and the biopharmaceutical industry to more readily exchange and analyze data related to the safe use of medical products.
Data and Safety Monitoring Board - An Overview
Presentation regarding history, purpose, role, functions, meeting, member responsibilities, report of a Data and Safety Monitoring Board (DSMB)
Medical Product Development cycle
The document provides an overview of the product development cycle for medical devices. It discusses that medical devices are highly regulated and must meet regulatory standards to be approved for use. The development process involves risk analysis, usability testing, clinical evaluation and verification to ensure safety and effectiveness for the intended use before a device can be certified and placed on the market. Standards provide guidelines for quality management, risk management, and specific product categories that must be followed.
FDA Regulation of Promotion & Advertising -- Part 1: The Basics
Presentation to the Compliance Online 2-day course on Ensuring Compliance with FDA Requirements for the Promotion & Advertising of Drugs and Medical Devices, March 22, 2018
summary of indian medical device rule 2017
This document outlines the key points of the Indian Medical Device Rules of 2017. It defines medical devices and explains why regulation is necessary. It describes the various authorities and bodies involved in enforcement and oversight. The rules cover the classification, manufacturing, import, labeling, clinical investigation, and sale of medical devices in India. Manufacturers must comply with quality management standards and obtain the necessary licenses from the Central or State Licensing Authorities depending on the class of device. Clinical investigations require approval and oversight from ethics committees. The rules aim to improve safety, quality and ensure medical devices meet appropriate standards.
PHARMACOVIGILANCE COMMON JOB INTERVIEW QUESTIONS WITH ANSWERS-Updated IN 202...
PHARMACOVIGILANCE COMMON JOB INTERVIEW QUESTIONS WITH ANSWERS-Updated IN 202...Pristyn Research Solutions
Quick Job interview short guide For Pharma and all Life science jobseekers.All Medical | Biotech |Micro |B.Sc., M.Sc.
These are the commonly asked questions with their answers asked in job interviews. The file was updated in 2022.
https://pristynresearch.com/
MAIL ID - pristynresearch@gmail.com
FACEBOOK- https://www.facebook.com/pristynsolutions
INSTAGRAM- https://www.instagram.com/pristyn_res...
TWITTER- https://twitter.com/Pristynresearch
SLIDESHARE- https://www.slideshare.net/azherkhan5916
LINKEDIN- https://www.linkedin.com/in/pristyn-research-191072119/
ADDRESS-
1) Parmar Trade Centre, A-wing,105/106, Sadhu Vaswani Chowk, Pune, 411001. Email: info@pristynresearch.com Phone: 09028839789
2)T-21/4, Opposite To Expert Global, Garware Stadium Road, Software Technology Park of India(STPI), MIDC, Aurangabad-431001. Email: info@pristynresearch.com Call us: 9028839789
Sample Questions are:
What is Pharmacovigilance (PV)?
What are the objectives of PV?
What is MedDRA?
WHAT ARE THE Role of Drug Safety
Associate?
What should narratives consist of?
What are Data assessments in PV?
Which products are covered by PV?
Methods of signal detection?
Why PV is required after clinical
trial?
What is an Adverse Drug Event (ADE)?
What
is the minimum criterion required
for a valid case according to WHO?
When
do you consider an event to be
serious?
What do you mean by causality?
Types of
Unsolicited reports
Sources of Solicited Reports
Name the core regulatory bodies
What is Volume 9A
What do you know
about E2a, E2b and E2c guidelines?
When do you consider a case to be medically confirmed?
What is CemFlow?
What is the yellow card in PV?
What are Comorbid conditions?
What is a medication error?
What is a signal?
Rechallenge
Dechallenge
What are WHO ART, WHO DD and MedDRA and the difference between them?
What is SUSAR?
Adverse Drug Reaction (ADR)
Effectiveness/risk
harm
Essential medicines
Frequency of ADRs
Individual Case Safety Report
ADR Reporting process in PV
VigiFlow
VigiMed
ABBOTTS
COGNIZANT
I 3 GLOBAL DRUG
SAFETY
LAURUS LABS
PARAXEL
SRISTEK
ACCENTURE
CREST.
I GATE PATNI
COMPUTERS
MAHINDRA
SATYAMBSG
PIRAMAL
SUN
PHARMA
ALEMBIC
DIAGNOSEAR
CH
ICON
MAKROCARE
PPD
SYMOGEN
APC PHARMA.
DR REDDY’S
iMEDGlobal,
MANKIND
QUANTUM
SOLUTIONS
SYNOGEN
APCER
ECRON
ACUNOVA
IMS HEALTH
MEDHIMALAYAS
QUINTILES
TAKE
SOLUTIONS
APCER
EMCURE
INC RESEARCH
MEDPACE.
SCIFORMIX
RATIOPHARM
TCS
ASTRAZENECA
FDC
Infocorp
Soft
Solutions
MICRO LABS
RX MD
THOMSON
REUTERS
AUROBINDO
FORTIS
HEALTH CARE
INVENTIVE
MSD (MERCK)
SANTHA
BIOTECH
USV
LIMITED
BESTOCHEM
G7 INFOTECH
IPCA
LABORATORIES
NEKTAR
THERAPEUTICS
SCIFORMIX.
VIMTA LABS
BIOCAD
GENPACT
IPLEX
NORWICH
CLINICAL SERVICES
SHANTHA
BIOTECHNICS
WIPRO
BIOCON
GRANULES
JUBILIANT
BIOSYS NOVARTIS
SIRO
CLINPHARM
WNS
BIOLOGICAL E.
LTD
GVK
KINAPSE
NOVO NORDISK
SP softtech
WOCKHARD
T
BLUEFISH
HCL
LAMBDA
OMNICARECLINICA
L RESEARCH
SRI KRISHNA
PHARMA
4C
Pharma
SolutionsClinical Data Review Best Practices - E. Herbel
The document summarizes best practices for clinical data review. Historically, clinical research associates reviewed 100% of paper case report forms and data was reviewed in exhaustive detail. However, this approach is now seen as inefficient. The current trend is for risk-based data review, where highest risk issues are prioritized. This allows reviewers to focus on important safety data and unexpected trends rather than getting bogged down in minor details. Effective data review examines data from aggregate summaries to identify trends, then allows drilling down to patient-level details to investigate further. Graphical aggregates like scatter plots and risk assessments are also useful review tools to detect outliers.
Safety monitoring and reporting of adverse events of medical devices national...
This document outlines safety monitoring and adverse event reporting for medical devices from national and international perspectives. It defines medical devices and their classification system. Approval processes in India are discussed, along with the Materiovigilance Program of India for post-marketing surveillance. Adverse events must be reported within defined timeframes. International regulatory bodies like the FDA and MHRA also have mandatory reporting requirements. The limitations of current monitoring and reporting are noted.
What's hot (20)
plasma master file in European countries and requirements in letter of intent...
plasma master file in European countries and requirements in letter of intent...
The In vitro diagnostic medical devices regulation (EU) 2017/746: what will c...
The In vitro diagnostic medical devices regulation (EU) 2017/746: what will c...
FDA Regulation of Promotion & Advertising -- Part 1: The Basics
FDA Regulation of Promotion & Advertising -- Part 1: The Basics
PHARMACOVIGILANCE COMMON JOB INTERVIEW QUESTIONS WITH ANSWERS-Updated IN 202...
PHARMACOVIGILANCE COMMON JOB INTERVIEW QUESTIONS WITH ANSWERS-Updated IN 202...
Safety monitoring and reporting of adverse events of medical devices national...
Safety monitoring and reporting of adverse events of medical devices national...
Viewers also liked
De vygview a #EdificioOptimista
El documento describe el proyecto de Vygon España para crear una nueva sede de oficinas llamada "Edificio Optimista" que refleje la filosofía y valores de la compañía. El artista Fernando Jiménez diseñó varias obras de arte para decorar las oficinas, incluyendo árboles, fotos y un mapamundi pintado por niños, con el objetivo de fomentar una cultura de optimismo, buen rollo y comunicación entre los empleados.
MEDICAL DEVICE DEVELOPMENT_0327
This document discusses challenges for inventors and investors in raising capital for medical device development. It outlines four levels of innovation risk from lowest to highest - marginal, technological, therapeutic, and radical. Radical innovation involving new technology and new clinical uses poses the highest uncertainty. The document also compares perspectives of inventors, who focus on developing products, and investors, who seek returns. Their differing goals can cause challenges in collaborating on ventures. Additional hurdles include regulatory requirements and changing markets and technologies.
Is your medical device idea viable?
A 50 page, easy-read E:Book taking you through the key considerations for deciding whether your Medical Device idea could eventually become a viable business.
Medical entrepreneurship
This document discusses medical entrepreneurship and provides examples of doctor entrepreneurs. It argues that doctors can and should be entrepreneurs given certain traits developed during medical training like focus and a desire to help others. It provides examples of doctor entrepreneurs who have started hospitals, clinics, and businesses. Specific examples discussed include an eye hospital in India that performs cheap cataract surgeries and a heart hospital in India that performs heart surgeries and dialysis for much lower costs through economies of scale. The document advocates for doctors to be innovative and create new treatments, procedures, medical equipment, and businesses to help patients and reform healthcare.
Funding A Medical Device Startup In The Current Economy
A presentation delivered June 4, 2009 describing the impact of the economic crisis on venture and angel investing and common sense steps for fundraising for Medical Device Startups. No one is an expert now.
Medical Device Reimbursement Process
Mediclever Ltd. provides regulatory, quality, reimbursement, and clinical research consulting services to life science start-ups in Europe and the USA. Their services include regulatory landscape reports, quality management system implementation, clinical study planning and execution, reimbursement strategy development, and applications for regulatory approval and reimbursement. They work in collaboration with partners who can coordinate and manage the provision of these services.
"Stan Lapidus: Profile of a Medical Entrepreneur."
Higgins, Robert F., and Sophie LaMontagne. "Stan Lapidus: Profile of a Medical Entrepreneur." Harvard Business School Case 805-087, December 2004. (Revised July 2010.)
Medical device management in china and latest regulatory updates_Edwin
Currently, China is one of the world's most promising markets for medical devices, which on the back of its vast market size, offers huge potential to medical device companies. All medical devices marketed or sold for use in China must be registered with China Food and Drug Administration (CFDA).
Swaps
This document summarizes different types of swap contracts. It begins with an overview of interest rate swaps, including how they allow entities to exchange fixed and variable rate financing. It then describes currency swaps, commodity swaps, credit default swaps, and equity swaps. For each type, it provides a definition and example to illustrate how the swap works. The presentation was given by Paulo Martins and Vilma Jordão to explain the role of swap contracts and how they can help companies manage financial risks.
Winning the battle_for_consumer_healthcare
This document discusses the emerging consumer healthcare market as major demographic shifts are increasing demand for products that promote health and wellness. Two industries - consumer goods companies and pharmaceutical companies - are competing to meet this demand. Consumer goods companies excel at marketing but must substantiate health claims, while pharmaceutical companies have strong scientific expertise but face declining drug revenues. It remains to be seen which type of company will dominate the consumer healthcare market by successfully meeting consumer needs through their strengths in either marketing or science.
Pedi Slideshare
This document summarizes the history and capabilities of Plastic Engineering and Development, Inc. (PEDI), a contract manufacturer of medical devices located in Carlsbad, CA. Key details include: PEDI was founded in 1985 and acquired in 2010 by Providien, LLC, which focuses on acquiring small medical device manufacturers; PEDI has extensive injection molding, clean room manufacturing, and assembly capabilities for medical devices; and PEDI provides design, tooling, production, packaging, and distribution services to its customers.
Despatch Ovens for Medical Device Manufacturing
This document describes various types of ovens used for medical device manufacturing and processing. It outlines ovens for curing coatings and adhesives, high performance drying, critical sterilization and decontamination, and the manufacturing process. Specific oven models are detailed including benchtop, clean process, continuous, reach-in, truck-in, and customized options. Each oven lists its maximum temperature, interior material, and additional features. Custom ovens can also be designed and manufactured.
Presentation: Life cycle of medical devices
This presentation provided an overview of the lifecycle approach to regulation & the importance of reporting incidents to the TGA
Business Incubator Blueprint: How to Open a Business Incubator and Maximize R...
Business Incubator Blueprint: How to Open a Business Incubator and Maximize R...Center For Entrepreneurial Innovation
The Center for Entrepreneurial Innovation (CEI) is a leading business incubator in Phoenix, Arizona, providing services and support to tech entrepreneurs in the region. This presentation, from Susie Pulido of the Maricopa Corporate College, will showcase how to build a incubation program and facility that offers relevance for startup companies for optimal impact and also diversified revenue streams for sustainability. *Note: This presentation was first given at the National Association for Community College Entrepreneurship (NACCE) 2015 Annual Conference in Houston, Texas; October 2015.GSK Consumer Healthcare presentation at InnoCosmetics Europe
This document discusses optimizing product performance through innovative formulations and cutting-edge technology. It provides examples using Pronamel toothpaste and mouthwash, which maximize available fluoride levels through careful ingredient selection like sodium fluoride and polymers. New technologies like DSIMS and light interferometry were used to study fluoride penetration into enamel and reduce erosion. Together, innovative formulations and technologies allow creating high performing products that deliver targeted benefits like reducing dental erosion.
Process Validation & Verification (V&V) for Medical Devices
This document is a presentation on process validation and verification. It discusses six focus areas for ensuring a consistent and controlled process from prototype to finished product: getting CEO commitment, establishing an interdisciplinary team, starting early in product development, knowing suppliers and subcontractors, mapping processes, and understanding sources of variability. It provides examples and advice for each area, such as creating a multidisciplinary team to understand all factors that could affect variability, developing a quality agreement with suppliers, and process mapping to get consensus on how processes are actually performed. The overarching message is that effective process validation requires a holistic and systematic approach across the entire organization.
Cimigo - Consumer Healthcare Trends 2015
This report looks at consumer healthcare trends in Vietnam, Asia. It explores drivers behind the growth in the pharmaceutical industry, changing attitudes to healthcare, prevalence of diseases and treatments. The report considers the relative influence of consumers, pharmacies and healthcare practitioners for marketing budgets.
Effective Medical Device Validation Introduction Web 2
This document provides an overview of the contents of a presentation on medical device compliance and validation. The presentation covers regulatory requirements, quality management systems, documentation, auditing, risk management, design controls, validation approaches across the product lifecycle including installation qualification, operation qualification, performance qualification and revalidation. It also discusses quality tools such as statistical process control.
Tablet Punching Machine, Rotary Tablet Press Machine, Dies and Punches
Being one of the best manufacturers, suppliers and exporters of Tablet Punching Machine, Rotary Tablet Press Machine, Dies and Punches and Tablet Compression Machine Spares in India.
The Marriage of Lean and MES in Medical Device Manufacturing - Jim Robinson, ...
The Marriage of Lean and MES in Medical Device Manufacturing - Jim Robinson, ...marcus evans Network
For more information contact: Slideshare@marcusevans.com.
The Marriage of Lean and MES in Medical Device Manufacturing - Presentation delivered by Speaker James Robinson, Vice President, Operations, Advanced Bionics, at the marcus evans Medical Device Manufacturing Summit held on June 25-26, in Las VegasViewers also liked (20)
Funding A Medical Device Startup In The Current Economy
Funding A Medical Device Startup In The Current Economy
"Stan Lapidus: Profile of a Medical Entrepreneur."
"Stan Lapidus: Profile of a Medical Entrepreneur."
Medical device management in china and latest regulatory updates_Edwin
Medical device management in china and latest regulatory updates_Edwin
Business Incubator Blueprint: How to Open a Business Incubator and Maximize R...
Business Incubator Blueprint: How to Open a Business Incubator and Maximize R...
GSK Consumer Healthcare presentation at InnoCosmetics Europe
GSK Consumer Healthcare presentation at InnoCosmetics Europe
Process Validation & Verification (V&V) for Medical Devices
Process Validation & Verification (V&V) for Medical Devices
Effective Medical Device Validation Introduction Web 2
Effective Medical Device Validation Introduction Web 2
Tablet Punching Machine, Rotary Tablet Press Machine, Dies and Punches
Tablet Punching Machine, Rotary Tablet Press Machine, Dies and Punches
The Marriage of Lean and MES in Medical Device Manufacturing - Jim Robinson, ...
The Marriage of Lean and MES in Medical Device Manufacturing - Jim Robinson, ...
Similar to Medical Device Development - Trends, Challenges and Risks
Personalized Medicine: Are we there yet?
Slides on the future of healthcare, entitled "Personalized Medicine: Are we there yet?" form a lecture given by Reid Robison, MD MBA at Brigham Young University in the College of Life Sciences in December 2014. The presentation covers the arrival of genome-guided precision medicine as well as the digital health movement and the shift towards a patient-centric, consumer-driven healthcare system.
Revolutionizing Healthcare The Biomedical Industry's Quest for Innovation
The document provides a comprehensive overview of the biomedical industry, examining its history, current challenges, and promising future developments. It traces the roots of biomedicine back to ancient civilizations and explores key milestones like the Renaissance period and modern discoveries of germ theory and antibiotics. Current challenges include navigating regulatory hurdles, addressing ethical dilemmas, and improving global healthcare access. Exciting areas of innovation discussed are precision medicine, regenerative medicine, artificial intelligence, 3D printing, and telemedicine. The future holds possibilities such as artificial organs and neurotechnology breakthroughs, though developing ethical frameworks and global collaboration will be important to ensure responsible progress.
From “Big Data” to Digital Medicine--PYA Explores Innovations in Healthcare
With reform in healthcare and advancements in technology, the future of medicine is in a state of flux. What it all means can be heard in discussions from coast-to-coast, in the halls of hospitals, at conferences, and in board rooms.
Among the thought leaders who have broached this timely subject is PYA Principal Kent Bottles, MD, who is also PYA Analytics’ Chief Medical Officer. He recently spoke at The North American Menopause Society Annual Meeting on the topic: “The Perils and Prospects of Practicing Medicine in a Digital Era.”
apidays LIVE India 2022_Analytics in Healthcare.pptx
This document discusses how artificial intelligence can help combat diabetes through predictive analytics, lifestyle guidance, and monitoring tools. It outlines conferences held by an analytics company to discuss these topics. Key challenges to adoption include integration issues, data privacy, lack of standards, and gaining acceptance from medical practitioners. However, AI shows promise in predicting glucose levels, personalized education, insulin guidance, and complication monitoring if these obstacles can be overcome.
Technology for Family Physicians- India
Dr. Jaya Bajaj discusses the importance of family physicians adopting technology. She outlines three main categories of medical technology: information technology, diagnostic technology, and therapeutic technology. Within information technology, she highlights the use of technology for practice management, managing medical knowledge, communications, and social media. For diagnostic technology, she mentions medical devices, point-of-care tools, and health monitoring devices. Therapeutic technologies include nanotechnology, gene therapy, and personalized medicine. Overall, Dr. Bajaj argues that family physicians should be leaders in adopting evidence-based and cost-effective technologies to improve patient care and outcomes, while selectively choosing technologies that meet principles of a successful practice.
Medical tech presentation
Medical technology refers to the field of advancing medical practices through technology to diagnose, assess, and treat diseases. The document discusses the history of major medical technology milestones from the 13th century to present day. Recent advances discussed include augmented reality for medical education, improved cancer immunotherapies and diabetes management tools, and gene editing technology. While medical technology provides benefits like improved health outcomes and economic benefits, it also presents risks such as data privacy concerns and over-reliance on technology. Overall, medical technology has become increasingly popular and transformative to healthcare.
Current Trends of Wearable Technology Devices in Clinical Diagnostics
Wearable devices are real-time, and noninvasive biosensors allow for the continuous monitoring of individuals and thus provide sufficient information for determining health status and even preliminary medical diagnosis. This presentation briefly introduces the latest advances in wearable healthcare systems, which can be used for real-time diagnosis and treatment of patients.
Dr. Leigh Anne Poole Lead Follow or Get Out Of The Way
This document discusses how technological innovations are transforming healthcare delivery. It outlines several innovations like telehealth, 3D printing, robotics, nanotechnology, and artificial intelligence that could change the healthcare system. These technologies may allow up to 50% of healthcare visits to be conducted remotely via telemedicine in the next 5 years. The document argues that the current healthcare system is experiencing a paradigm shift from traditional to more modern approaches as a result of disruptive technologies.
Day 1: 9:15am-10:45am Panel Slides (Nov 18) Access to Innovation Conference
Day 1: 9:15am-10:45am Panel Slides (Nov 18) Access to Innovation ConferenceCanadian Organization for Rare Disorders
Why Precision Medicine and Personalized Healthcare and Why Now? Links to Canada’s Rare Disease Strategy The Future is Now
1) Marc LePage, Genome Canada
2) Michael Duong, Roche
3) Danica Stanimirovic, National Research Council
4) Daniel Gaudet, University of Montreal
5) Christine Dalgleish, Patient Perspective
6) Jamie Bruce, Khure Health
The Extreme Future of Health Care 2014
Radical trends in health care and medicine will change business and society. This presentation fresh from Dr. James Canton's New Keynote Presentation and from his upcoming new book looks at the trends in biotech, synthetic biology, digital health, genomics, wellness and regenerative medicine that will shape the near future of our world and health. Find out what's next and how to prepare today. For more info see http://globalfuturist.com
Role of AI in Transforming the Healthcare Industry
The document discusses the role of artificial intelligence in transforming the healthcare industry. It provides an overview of how AI is being applied in domains like medical imaging, diagnostics, personalized healthcare, data-driven decision making, and healthcare communication. It also describes some projects at CoDTeEM, a research group applying AI to solve local healthcare problems. Some challenges and limitations of AI in healthcare are mentioned, such as issues regarding adoption, performance, privacy, interpretability, and trust.
The Digital KOL 6.2015
The document discusses the rise of digital physician key opinion leaders (KOLs) as a new paradigm in healthcare. Digital KOLs are physician experts who are also leaders in social media and champions of patient engagement and digital tools. They serve as advisors to digital health companies, help design medical apps and mobile clinical trials, and disseminate health information via social media to both professionals and patients. The digital age requires a new approach from the pharmaceutical industry, and digital physician KOLs can help drive this transition by promoting digital interactions and partnerships.
121213 bmi and emergency physician
- Bio-Medical Informatics (BMI) is the interdisciplinary field that studies and pursues the effective uses of biomedical data, information, and knowledge for scientific inquiry, problem solving, and decision making, motivated by efforts to improve human health.
- Emergency Medical Informatics (EMI) applies BMI principles to emergency patient care and operations by facilitating the collection, management, processing, and application of emergency patient care and operational data.
- As an emergency physician, it is important to ensure that any emergency department information system (EDIS) is safe, effective, and patient-centered, and to find ways to measure its impact and make it more valuable for clinical practice and research. National organizations like the Korean
Medical devices 2004
This document summarizes the medical device industry in British Columbia. It notes that the industry employs over 3,000 people at around 200 companies and generates $270 million annually. The industry has strengths in specialty niche products, strong research infrastructure, and government support. The document discusses how technologies are converging, with examples of devices that combine areas like biotechnology, advanced materials, and wireless capabilities. It predicts future convergence involving nanotechnology, micro fuel cells, brain-computer interfaces, and advanced power sources. The key takeaway is that the medical device field is advancing through convergence of technologies.
Digital Health Technology: The Ultimate Patient Advocate
Digital technologies like wireless sensors, genomics, EHRs, mobile apps, and big data analytics can significantly help patients but cannot replace human compassion and advocacy. These technologies can improve patient engagement, access to information, and personalized care. However, the most effective patient advocates will still be human beings who can combine technology tools with qualities like empathy, communication skills, and devotion of time to help patients navigate the healthcare system.
Rj imminent transformations in health shanghai 170510
Fundamental nature of health is changing. Current healthcare is legacy of caring infectious diseases, while chronic diseases are now the most prevalent in most societies. Health should be considered as a metanexus of genetics, lifestyle, environment, socio-economic situation and medical knowledge
apidays LIVE Singapore 2022_Analytics in Healthcare.pptx
apidays LIVE Singapore 2022: Digitising at scale with APIs
April 20 & 21, 2022
Analytics in Healthcare: combating diabetes with data
Dr Nashya Haider, Founder & Director at Innotech Consultants
------------
Check out our conferences at https://www.apidays.global/
Do you want to sponsor or talk at one of our conferences?
https://apidays.typeform.com/to/ILJeAaV8
Learn more on APIscene, the global media made by the community for the community:
https://www.apiscene.io
Explore the API ecosystem with the API Landscape:
https://apilandscape.apiscene.io/
Deep dive into the API industry with our reports:
https://www.apidays.global/industry-reports/
Subscribe to our global newsletter:
https://apidays.typeform.com/to/i1MPEW
The Art of Healthcare Innovation
This document provides an overview and summary of the book "The Art of Healthcare Innovation" by Christina D. Warner. The book is based on over 200 interviews with healthcare pioneers, leaders, and innovators. It aims to help readers understand the future healthcare landscape and identify opportunities. The summary highlights key sections of the book, including the patient journey, insights from industry leaders, the evolving healthcare environment, and a conclusion on the importance of anticipating disruption. The author's background and qualifications are also summarized.
Future of healthcare
Mike Jackson, Chairman of Shaping Tomorrow, presented on the future of healthcare. Key points include:
1) Healthcare systems have lagged 10 years in translating clinical research into practice, neglecting major health issues. Continuous scanning is needed to enable preventative and predictive care.
2) Future healthcare will be predictive, preventative, precise, participatory and personalized through technologies like genomics, digital implants, and mobile health monitoring.
3) By 2025, patients will be at the center of their own care, aided by new technologies, while universal genetics and regenerative medicine become standard. Healthcare will increasingly shift to the home instead of institutions.
Digital Health IT for putting patients first
This document discusses how technology can help put patients first by improving healthcare delivery through electronic medical records, telemedicine, mobile health apps, and other digital innovations. However, it notes that meaningful change requires addressing challenges such as interoperability issues, usability problems, engaging patients, changing behaviors, and demonstrating clear returns on investment. Overall, technology must be developed and implemented carefully in partnership with doctors to truly benefit patients.
Similar to Medical Device Development - Trends, Challenges and Risks (20)
Revolutionizing Healthcare The Biomedical Industry's Quest for Innovation
Revolutionizing Healthcare The Biomedical Industry's Quest for Innovation
From “Big Data” to Digital Medicine--PYA Explores Innovations in Healthcare
From “Big Data” to Digital Medicine--PYA Explores Innovations in Healthcare
apidays LIVE India 2022_Analytics in Healthcare.pptx
apidays LIVE India 2022_Analytics in Healthcare.pptx
Current Trends of Wearable Technology Devices in Clinical Diagnostics
Current Trends of Wearable Technology Devices in Clinical Diagnostics
Dr. Leigh Anne Poole Lead Follow or Get Out Of The Way
Dr. Leigh Anne Poole Lead Follow or Get Out Of The Way
Day 1: 9:15am-10:45am Panel Slides (Nov 18) Access to Innovation Conference
Day 1: 9:15am-10:45am Panel Slides (Nov 18) Access to Innovation Conference
Role of AI in Transforming the Healthcare Industry
Role of AI in Transforming the Healthcare Industry
Digital Health Technology: The Ultimate Patient Advocate
Digital Health Technology: The Ultimate Patient Advocate
Rj imminent transformations in health shanghai 170510
Rj imminent transformations in health shanghai 170510
apidays LIVE Singapore 2022_Analytics in Healthcare.pptx
apidays LIVE Singapore 2022_Analytics in Healthcare.pptx
Recently uploaded
Stork Product Overview: An AI-Powered Autonomous Delivery Fleet
Imagine a world where instead of blue and brown trucks dropping parcels on our porches, a buzzing drove of drones delivered our goods. Now imagine those drones are controlled by 3 purpose-built AI designed to ensure all packages were delivered as quickly and as economically as possible That's what Stork is all about.
How Can Hiring A Mobile App Development Company Help Your Business Grow?
ToXSL Technologies is an award-winning Mobile App Development Company in Dubai that helps businesses reshape their digital possibilities with custom app services. As a top app development company in Dubai, we offer highly engaging iOS & Android app solutions. https://rb.gy/necdnt
ppt on the brain chip neuralink.pptx
A neural network is a machine learning program, or model, that makes decisions in a manner similar to the human brain, by using processes that mimic the way biological neurons work together to identify phenomena, weigh options and arrive at conclusions.
WWDC 2024 Keynote Review: For CocoaCoders Austin
Overview of WWDC 2024 Keynote Address.
Covers: Apple Intelligence, iOS18, macOS Sequoia, iPadOS, watchOS, visionOS, and Apple TV+.
Understandable dialogue on Apple TV+
On-device app controlling AI.
Access to ChatGPT with a guest appearance by Chief Data Thief Sam Altman!
App Locking! iPhone Mirroring! And a Calculator!!
How GenAI Can Improve Supplier Performance Management.pdf
Data Collection and Analysis with GenAI enables organizations to gather, analyze, and visualize vast amounts of supplier data, identifying key performance indicators and trends. Predictive analytics forecast future supplier performance, mitigating risks and seizing opportunities. Supplier segmentation allows for tailored management strategies, optimizing resource allocation. Automated scorecards and reporting provide real-time insights, enhancing transparency and tracking progress. Collaboration is fostered through GenAI-powered platforms, driving continuous improvement. NLP analyzes unstructured feedback, uncovering deeper insights into supplier relationships. Simulation and scenario planning tools anticipate supply chain disruptions, supporting informed decision-making. Integration with existing systems enhances data accuracy and consistency. McKinsey estimates GenAI could deliver $2.6 trillion to $4.4 trillion in economic benefits annually across industries, revolutionizing procurement processes and delivering significant ROI.
Why Apache Kafka Clusters Are Like Galaxies (And Other Cosmic Kafka Quandarie...
Closing talk for the Performance Engineering track at Community Over Code EU (Bratislava, Slovakia, June 5 2024) https://eu.communityovercode.org/sessions/2024/why-apache-kafka-clusters-are-like-galaxies-and-other-cosmic-kafka-quandaries-explored/ Instaclustr (now part of NetApp) manages 100s of Apache Kafka clusters of many different sizes, for a variety of use cases and customers. For the last 7 years I’ve been focused outwardly on exploring Kafka application development challenges, but recently I decided to look inward and see what I could discover about the performance, scalability and resource characteristics of the Kafka clusters themselves. Using a suite of Performance Engineering techniques, I will reveal some surprising discoveries about cosmic Kafka mysteries in our data centres, related to: cluster sizes and distribution (using Zipf’s Law), horizontal vs. vertical scalability, and predicting Kafka performance using metrics, modelling and regression techniques. These insights are relevant to Kafka developers and operators.
TMU毕业证书精仿办理
多伦多都会大学毕业证成绩单(留信网认证)【176555708微信】不能毕业办理假文凭回国找工作
【多伦多都会大学毕业证成绩单仿制】（176555708微信☀️）伪造研究生学位证书TMU毕业证文凭,多伦多都会大学文凭证书学籍信息入库,多伦多都会大学学位证书留学高校学位证书补办
【TMU毕业证【微信176555708】多伦多都会大学文凭学历】【微信176555708】【多伦多都会大学文凭学历证书】【多伦多都会大学毕业证书与成绩单样本图片】毕业证书补办 Fake Degree做学费单【毕业证明信-推荐信】成绩单，录取通知书，Offer，在读证明，雅思托福成绩单，真实大使馆教育部认证，回国人员证明，留信网认证。网上存档永久可查！
Unlock the Secrets to Effortless Video Creation with Invideo: Your Ultimate G...
Unlock the Secrets to Effortless Video Creation with Invideo: Your Ultimate G...The Third Creative Media
"Navigating Invideo: A Comprehensive Guide" is an essential resource for anyone looking to master Invideo, an AI-powered video creation tool. This guide provides step-by-step instructions, helpful tips, and comparisons with other AI video creators. Whether you're a beginner or an experienced video editor, you'll find valuable insights to enhance your video projects and bring your creative ideas to life.Superpower Your Apache Kafka Applications Development with Complementary Open...
Kafka Summit talk (Bangalore, India, May 2, 2024, https://events.bizzabo.com/573863/agenda/session/1300469 )
Many Apache Kafka use cases take advantage of Kafka’s ability to integrate multiple heterogeneous systems for stream processing and real-time machine learning scenarios. But Kafka also exists in a rich ecosystem of related but complementary stream processing technologies and tools, particularly from the open-source community. In this talk, we’ll take you on a tour of a selection of complementary tools that can make Kafka even more powerful. We’ll focus on tools for stream processing and querying, streaming machine learning, stream visibility and observation, stream meta-data, stream visualisation, stream development including testing and the use of Generative AI and LLMs, and stream performance and scalability. By the end you will have a good idea of the types of Kafka “superhero” tools that exist, which are my favourites (and what superpowers they have), and how they combine to save your Kafka applications development universe from swamploads of data stagnation monsters!
The Comprehensive Guide to Validating Audio-Visual Performances.pdf
Ensuring the optimal performance of your audio-visual (AV) equipment is crucial for delivering exceptional experiences. AV performance validation is a critical process that verifies the quality and functionality of your AV setup. Whether you're a content creator, a business conducting webinars, or a homeowner creating a home theater, validating your AV performance is essential.
Modelling Up - DDDEurope 2024 - Amsterdam
What to do when you have a perfect model for your software but you are constrained by an imperfect business model?
This talk explores the challenges of bringing modelling rigour to the business and strategy levels, and talking to your non-technical counterparts in the process.
Enhanced Screen Flows UI/UX using SLDS with Tom Kitt
Join us for an engaging session led by Flow Champion, Tom Kitt. This session will dive into a technique of enhancing the user interfaces and user experiences within Screen Flows using the Salesforce Lightning Design System (SLDS). This technique uses Native functionality, with No Apex Code, No Custom Components and No Managed Packages required.
如何办理(hull学位证书)英国赫尔大学毕业证硕士文凭原版一模一样
原版定制【微信:bwp0011】《(hull学位证书)英国赫尔大学毕业证硕士文凭》【微信:bwp0011】成绩单 、雅思、外壳、留信学历认证永久存档查询，采用学校原版纸张、特殊工艺完全按照原版一比一制作（包括：隐形水印，阴影底纹，钢印LOGO烫金烫银，LOGO烫金烫银复合重叠，文字图案浮雕，激光镭射，紫外荧光，温感，复印防伪）行业标杆！精益求精，诚心合作，真诚制作！多年品质 ,按需精细制作，24小时接单,全套进口原装设备，十五年致力于帮助留学生解决难题，业务范围有加拿大、英国、澳洲、韩国、美国、新加坡，新西兰等学历材料，包您满意。
【业务选择办理准则】
一、工作未确定，回国需先给父母、亲戚朋友看下文凭的情况，办理一份就读学校的毕业证【微信bwp0011】文凭即可
二、回国进私企、外企、自己做生意的情况，这些单位是不查询毕业证真伪的，而且国内没有渠道去查询国外文凭的真假，也不需要提供真实教育部认证。鉴于此，办理一份毕业证【微信bwp0011】即可
三、进国企，银行，事业单位，考公务员等等，这些单位是必需要提供真实教育部认证的，办理教育部认证所需资料众多且烦琐，所有材料您都必须提供原件，我们凭借丰富的经验，快捷的绿色通道帮您快速整合材料，让您少走弯路。
留信网认证的作用:
1:该专业认证可证明留学生真实身份
2:同时对留学生所学专业登记给予评定
3:国家专业人才认证中心颁发入库证书
4:这个认证书并且可以归档倒地方
5:凡事获得留信网入网的信息将会逐步更新到个人身份内，将在公安局网内查询个人身份证信息后，同步读取人才网入库信息
6:个人职称评审加20分
7:个人信誉贷款加10分
8:在国家人才网主办的国家网络招聘大会中纳入资料，供国家高端企业选择人才
【关于价格问题（保证一手价格）】
我们所定的价格是非常合理的，而且我们现在做得单子大多数都是代理和回头客户介绍的所以一般现在有新的单子 我给客户的都是第一手的代理价格，因为我想坦诚对待大家 不想跟大家在价格方面浪费时间
对于老客户或者被老客户介绍过来的朋友，我们都会适当给一些优惠。
一比一原版(sdsu毕业证书)圣地亚哥州立大学毕业证如何办理
原版一模一样【微信：741003700 】【(sdsu毕业证书)圣地亚哥州立大学毕业证成绩单】【微信：741003700 】学位证，留信认证（真实可查，永久存档）原件一模一样纸张工艺/offer、雅思、外壳等材料/诚信可靠,可直接看成品样本，帮您解决无法毕业带来的各种难题！外壳，原版制作，诚信可靠，可直接看成品样本。行业标杆！精益求精，诚心合作，真诚制作！多年品质 ,按需精细制作，24小时接单,全套进口原装设备。十五年致力于帮助留学生解决难题，包您满意。
本公司拥有海外各大学样板无数，能完美还原。
1:1完美还原海外各大学毕业材料上的工艺：水印，阴影底纹，钢印LOGO烫金烫银，LOGO烫金烫银复合重叠。文字图案浮雕、激光镭射、紫外荧光、温感、复印防伪等防伪工艺。材料咨询办理、认证咨询办理请加学历顾问Q/微741003700
【主营项目】
一.毕业证【q微741003700】成绩单、使馆认证、教育部认证、雅思托福成绩单、学生卡等！
二.真实使馆公证(即留学回国人员证明,不成功不收费)
三.真实教育部学历学位认证（教育部存档！教育部留服网站永久可查）
四.办理各国各大学文凭(一对一专业服务,可全程监控跟踪进度)
如果您处于以下几种情况：
◇在校期间，因各种原因未能顺利毕业……拿不到官方毕业证【q/微741003700】
◇面对父母的压力，希望尽快拿到；
◇不清楚认证流程以及材料该如何准备；
◇回国时间很长，忘记办理；
◇回国马上就要找工作，办给用人单位看；
◇企事业单位必须要求办理的
◇需要报考公务员、购买免税车、落转户口
◇申请留学生创业基金
留信网认证的作用:
1:该专业认证可证明留学生真实身份
2:同时对留学生所学专业登记给予评定
3:国家专业人才认证中心颁发入库证书
4:这个认证书并且可以归档倒地方
5:凡事获得留信网入网的信息将会逐步更新到个人身份内，将在公安局网内查询个人身份证信息后，同步读取人才网入库信息
6:个人职称评审加20分
7:个人信誉贷款加10分
8:在国家人才网主办的国家网络招聘大会中纳入资料，供国家高端企业选择人才
办理(sdsu毕业证书)圣地亚哥州立大学毕业证【微信：741003700 】外观非常简单，由纸质材料制成，上面印有校徽、校名、毕业生姓名、专业等信息。
办理(sdsu毕业证书)圣地亚哥州立大学毕业证【微信：741003700 】格式相对统一，各专业都有相应的模板。通常包括以下部分：
校徽：象征着学校的荣誉和传承。
校名:学校英文全称
授予学位：本部分将注明获得的具体学位名称。
毕业生姓名：这是最重要的信息之一，标志着该证书是由特定人员获得的。
颁发日期：这是毕业正式生效的时间，也代表着毕业生学业的结束。
其他信息：根据不同的专业和学位，可能会有一些特定的信息或章节。
办理(sdsu毕业证书)圣地亚哥州立大学毕业证【微信：741003700 】价值很高，需要妥善保管。一般来说，应放置在安全、干燥、防潮的地方，避免长时间暴露在阳光下。如需使用，最好使用复印件而不是原件，以免丢失。
综上所述，办理(sdsu毕业证书)圣地亚哥州立大学毕业证【微信：741003700 】是证明身份和学历的高价值文件。外观简单庄重，格式统一，包括重要的个人信息和发布日期。对持有人来说，妥善保管是非常重要的。
A Comprehensive Guide on Implementing Real-World Mobile Testing Strategies fo...
In today's fiercely competitive mobile app market, the role of the QA team is pivotal for continuous improvement and sustained success. Effective testing strategies are essential to navigate the challenges confidently and precisely. Ensuring the perfection of mobile apps before they reach end-users requires thoughtful decisions in the testing plan.
The Rising Future of CPaaS in the Middle East 2024
Explore "The Rising Future of CPaaS in the Middle East in 2024" with this comprehensive PPT presentation. Discover how Communication Platforms as a Service (CPaaS) is transforming communication across various sectors in the Middle East.
Operational ease MuleSoft and Salesforce Service Cloud Solution v1.0.pptx
Operational ease MuleSoft and Salesforce Service Cloud Solution v1.0
ACE - Team 24 Wrapup event at ahmedabad.
Atlassian Team 24 event wrap-up Ahmedabad. Recap of Atlassian team24 event.
Recently uploaded (20)
Stork Product Overview: An AI-Powered Autonomous Delivery Fleet
Stork Product Overview: An AI-Powered Autonomous Delivery Fleet
How Can Hiring A Mobile App Development Company Help Your Business Grow?
How Can Hiring A Mobile App Development Company Help Your Business Grow?
How GenAI Can Improve Supplier Performance Management.pdf
How GenAI Can Improve Supplier Performance Management.pdf
Why Apache Kafka Clusters Are Like Galaxies (And Other Cosmic Kafka Quandarie...
Why Apache Kafka Clusters Are Like Galaxies (And Other Cosmic Kafka Quandarie...
Unlock the Secrets to Effortless Video Creation with Invideo: Your Ultimate G...
Unlock the Secrets to Effortless Video Creation with Invideo: Your Ultimate G...
Superpower Your Apache Kafka Applications Development with Complementary Open...
Superpower Your Apache Kafka Applications Development with Complementary Open...
The Comprehensive Guide to Validating Audio-Visual Performances.pdf
The Comprehensive Guide to Validating Audio-Visual Performances.pdf
Enhanced Screen Flows UI/UX using SLDS with Tom Kitt
Enhanced Screen Flows UI/UX using SLDS with Tom Kitt
A Comprehensive Guide on Implementing Real-World Mobile Testing Strategies fo...
A Comprehensive Guide on Implementing Real-World Mobile Testing Strategies fo...
The Rising Future of CPaaS in the Middle East 2024
The Rising Future of CPaaS in the Middle East 2024
Operational ease MuleSoft and Salesforce Service Cloud Solution v1.0.pptx
Operational ease MuleSoft and Salesforce Service Cloud Solution v1.0.pptx
Medical Device Development - Trends, Challenges and Risks
- 7. MedicalTrends Today • Customer tailored medicine - Personal Medicine • Repair, restore, replace organs, tissues, cells • Global and instant access to medical info • Homecare health • Mobile medicine • Prevention • Healthcare & Wellness
- 11. Biomedical Science • Genomics • Stem Cells • Vaccines • Pharmaceutical • Diagnosis
- 12. Computer / Engineering • Devices: Small, powerful • Imaging: not just X-Ray • OR of the future • Medical Info managing • Telemedicine • Mobile technology • Robotics • 3D printing of organs • Nanotechnology • Brain-computer interface
- 13. Sciences Trends Digital Medicine Robotic Surgery Nanomedicine Genomics Neuro Connected Health
- 15. Global Medical Challenges • Chronic diseases • Baby boom generation • Live longer • Life style • Physicians/patient ratio • Regulation of Innovation • Healthcare reforms • Healthcare costs • World wide environment
- 16. Global Medical Challenges Cost Demographics Access Variation in clinical practice Insufficient Use of information Fragmented care versus integrated care Duplication, defensive medicine & waste Protracted Adoption of Innovation
- 18. Technological Challenges • Electronics • Mechanics • Software • IT networking • Cyber security • Multimodality • Maintenance • Usability
- 19. Software Strengths • Operation system • Powerful computing • Smartphones • Embedded • Graphical cards • Open source • Libraries • Knowledge sharing
- 21. Risks: Medical/ Technological/ Regulation • R&D hurdles/technology • Time to market • Competition • IPs • Costs/Revenue • Reimbursement • Payers: customers • Risks from payers to providers • Global crisis
- 22. www.meddev-design.com Medical Devices Lifecycle Healthcare Delivery Process Treatment Rehabilitatio n Diagnosis Prevention Use of Medical Device Knowledge Creation Medical Device - Lifecycle
- 23. SWOT
- 24. AboutUs
- 25. Thank you We welcome you to visit our company booth